The transforming growth factor beta system in kidney disease and repair: recent progress and future directions

Area of Science:

• Nephrology
• Molecular Biology
• Pathophysiology

Background:

• Transforming growth factor beta (TGF-β) is a critical cytokine involved in numerous cellular processes.
• Its dysregulation is implicated in the pathogenesis of various renal diseases, particularly fibrosis.
• TGF-β plays a dual role, contributing to both disease progression and normal tissue repair following injury.

Purpose of the Study:

• To elucidate the factors and mechanisms regulating TGF-β activity in the context of renal injury and disease.
• To understand how TGF-β mediates extracellular matrix synthesis and contributes to renal fibrosis.
• To identify potential therapeutic targets for managing renal diseases associated with TGF-β dysregulation.

Main Methods:

• Review of in-vitro and in-vivo studies examining TGF-β regulation.
• Analysis of factors influencing TGF-β expression and activity.
• Investigation of transcriptional and post-transcriptional regulatory mechanisms.

Main Results:

• TGF-β expression is elevated in renal diseases, promoting extracellular matrix synthesis and leading to fibrosis.
• TGF-β is also involved in normal renal repair processes after injury.
• Factors such as proteolytic activity, thrombospondin-1, elevated glucose, angiotensin II, oxidant stress, and hemodynamic forces modulate TGF-β activity.
• Regulation occurs through both transcriptional and post-transcriptional pathways.

Conclusions:

• Inappropriate regulation of TGF-β expression is a key factor in the development of renal diseases.
• Understanding the mediators of TGF-β activity is essential for deciphering mechanisms of renal disease and repair.
• Therapies targeting TGF-β activity show potential in slowing the progression of end-stage renal disease.